DECT in Imaging Patients With Solid Organ Cancer With Intracranial Metastasis
- Conditions
- Metastatic Malignant Neoplasm in the BrainMalignant Neoplasm
- Interventions
- Procedure: Dual-Energy Computed Tomography
- Registration Number
- NCT03685539
- Lead Sponsor
- M.D. Anderson Cancer Center
- Brief Summary
This trial studies how well dual energy computed tomography (DECT) works in imaging patients with solid organ cancer that has spread to the brain. Imaging techniques, such as DECT, may help find and diagnose tumor cells and find out how far the tumor cells have spread in the brain.
- Detailed Description
PRIMARY OBJECTIVES:
I. To optimize two major parameters of computed tomography (CT) imaging for optimal detection of intracranial metastatic lesions.
Ia. Virtual monochromatic image reconstruction. Ib. Contrast bolus timing. II. To measure the detection accuracy of CT compared to the diagnostic standard of care gadolinium-based "Gamma Knife (GK)" protocol magnetic resonance imaging (MRI).
OUTLINE:
Within 7 days before the standard Gamma Knife MRI, patients undergo DECT scan over 6 seconds at 1.5, 5, 10, and 20 minutes after receiving the contrast agent.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 42
-
Adult patient with pathology-proven solid organ cancer
-
MRI of the brain with contrast, positive for two or more metastatic lesions
- One lesion with a single greatest diameter on contrast-enhanced MRI of 1 cm or greater
-
Planned treatment with stereotactic radiosurgery
- Known allergy to iodine-based contrast agents
- Patients with glomerular filtration rate (GFR) less than 30 or use of hemodialysis
- If prior nephrectomy, GFR less than 60
- Prior central nervous system malignancy
- Prior brain radiation
- Pregnant women are excluded
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Diagnostic (DECT) Dual-Energy Computed Tomography Within 7 days before the standard Gamma Knife MRI, patients undergo DECT scan over 6 seconds at 1.5, 5, 10, and 20 minutes after receiving the contrast agent.
- Primary Outcome Measures
Name Time Method Best diagnostic performance of computed tomography (CT) reconstruction parameters Up to 2 years A repeated-measures analysis of variance with the Dunnett post hoc test will be used to determine the significance of the differences in the signal-to-noise (SNR) and contrast-to-noise (CNR) measurements at the optimal parameter setting, compared with all other parameter settings.
Accuracy of CT Up to 2 years A Bland-Altman analysis will be used to show the agreement of number of lesions between optimal parametrized CT and the one of standard of care magnetic resonance imaging (MRI).
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
M D Anderson Cancer Center
🇺🇸Houston, Texas, United States